NO904839L - Fremgangsmaate for fremstilling av benzoxazinderivater. - Google Patents

Fremgangsmaate for fremstilling av benzoxazinderivater.

Info

Publication number
NO904839L
NO904839L NO90904839A NO904839A NO904839L NO 904839 L NO904839 L NO 904839L NO 90904839 A NO90904839 A NO 90904839A NO 904839 A NO904839 A NO 904839A NO 904839 L NO904839 L NO 904839L
Authority
NO
Norway
Prior art keywords
procedure
benzoxazine derivatives
preparing benzoxazine
preparing
derivatives
Prior art date
Application number
NO90904839A
Other languages
English (en)
Norwegian (no)
Other versions
NO904839D0 (no
Inventor
Yuzo Matsumoto
Ryuji Tsuzuki
Akira Matsuhisa
Kazuhisa Takayama
Wataru Uchida
Masaharu Asano
Toru Yoden
Isao Yanagisawa
Original Assignee
Yamanouchi Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi Pharma Co Ltd filed Critical Yamanouchi Pharma Co Ltd
Publication of NO904839D0 publication Critical patent/NO904839D0/no
Publication of NO904839L publication Critical patent/NO904839L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
    • C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO90904839A 1989-11-08 1990-11-07 Fremgangsmaate for fremstilling av benzoxazinderivater. NO904839L (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP29072789 1989-11-08
JP31592689 1989-12-05
JP34293789 1989-12-28
JP20854890 1990-08-06

Publications (2)

Publication Number Publication Date
NO904839D0 NO904839D0 (no) 1990-11-07
NO904839L true NO904839L (no) 1991-05-10

Family

ID=27476415

Family Applications (1)

Application Number Title Priority Date Filing Date
NO90904839A NO904839L (no) 1989-11-08 1990-11-07 Fremgangsmaate for fremstilling av benzoxazinderivater.

Country Status (11)

Country Link
EP (1) EP0432893A3 (US07825116-20101102-C00007.png)
JP (1) JPH0774208B2 (US07825116-20101102-C00007.png)
KR (1) KR950007757B1 (US07825116-20101102-C00007.png)
AU (1) AU641953B2 (US07825116-20101102-C00007.png)
FI (1) FI905510A0 (US07825116-20101102-C00007.png)
HU (1) HU211282A9 (US07825116-20101102-C00007.png)
IE (1) IE904013A1 (US07825116-20101102-C00007.png)
NO (1) NO904839L (US07825116-20101102-C00007.png)
PH (1) PH30439A (US07825116-20101102-C00007.png)
PT (1) PT95798A (US07825116-20101102-C00007.png)
TW (1) TW224941B (US07825116-20101102-C00007.png)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ222843A (en) * 1986-12-22 1989-10-27 Ortho Pharma Corp Benzoxazinyl- and benzothiazinyl-tetrahydropyridazinones and intermediates, and medicaments
CN1060467A (zh) * 1990-09-25 1992-04-22 武田药品工业株式会社 1，3-苯并嗪衍生物、其生产方法和用途
CA2061179A1 (en) * 1991-02-18 1992-08-19 Ryuji Tsuzuki Oxzazinobenzazole compounds
US5262419A (en) * 1992-06-11 1993-11-16 E. R. Squibb & Sons, Inc. Method for the prophylaxis and/or treatment of ulcerative gastrointestinal conditions using a potassium channel activator
JPH06220029A (ja) * 1992-12-03 1994-08-09 Ss Pharmaceut Co Ltd １，４−ベンズオキサジン誘導体
GB9225860D0 (en) * 1992-12-11 1993-02-03 Smithkline Beecham Plc Novel treatment
GB9225859D0 (en) * 1992-12-11 1993-02-03 Smithkline Beecham Plc Novel treatment
AU5979494A (en) * 1993-02-05 1994-08-29 Yamanouchi Pharmaceutical Co., Ltd. Novel benzoxazine derivative, medicine containing the same, and intermediate therefor
GB9309716D0 (en) * 1993-05-12 1993-06-23 Zeneca Ltd Heterocyclic derivatives
JP3662929B2 (ja) * 1994-06-09 2005-06-22 エスエス製薬株式会社 ４−キノリノン誘導体又はその塩
US6218411B1 (en) * 1997-08-08 2001-04-17 Chugai Seiyaku Kabushiki Kaisha Therapeutics for diabetic complications
KR100466809B1 (ko) * 1998-06-30 2006-01-27 씨제이 주식회사 즉석닭튀김식품의제조방법
WO2000012492A1 (en) * 1998-09-01 2000-03-09 Nissan Chemical Industries, Ltd. Benzoxazine derivatives
US6455554B1 (en) 1999-06-07 2002-09-24 Targacept, Inc. Oxopyridinyl pharmaceutical compositions and methods for use
WO2002072049A1 (fr) * 2001-02-27 2002-09-19 Yamanouchi Pharmaceutical Co., Ltd. Compositions medicamenteuses servant a stimuler la croissance capillaire
US6951855B2 (en) * 2001-04-23 2005-10-04 Astrazeneca Ab Benzoxazinone derivatives for use in the treatment of angiogenesis
TWI329105B (en) 2002-02-01 2010-08-21 Rigel Pharmaceuticals Inc 2,4-pyrimidinediamine compounds and their uses
CN1678321A (zh) 2002-07-29 2005-10-05 里格尔药品股份有限公司 用2,4－嘧啶二胺化合物治疗或者预防自体免疫性疾病的方法
EP1656372B1 (en) 2003-07-30 2013-04-10 Rigel Pharmaceuticals, Inc. 2,4-pyrimidinediamine compounds for use in the treatment or prevention of autoimmune diseases
WO2005105776A1 (en) * 2004-05-05 2005-11-10 F. Hoffmann-La Roche Ag Arylsulfonyl benzodioxanes useful for modulation the 5-ht6 receptor, the 5-ht2areceptor or both
US7378415B2 (en) 2004-09-30 2008-05-27 Roche Palo Alto Llc Benzoxazine and quinoxaline derivatives and uses thereof
NZ553848A (en) * 2004-09-30 2010-01-29 Hoffmann La Roche Benzoxazine and quinoxaline derivatives and their use in treating diseases associated with the central nervous system
GB0428526D0 (en) 2004-12-30 2005-02-09 Novartis Ag Organic compounds
PT1856135E (pt) 2005-01-19 2010-02-26 Rigel Pharmaceuticals Inc Pró-fármacos de compostos 2,4-pirimidinodiamina e suas utilizações
KR20080086921A (ko) 2005-12-30 2008-09-26 노파르티스 아게 레닌 억제제로서의 ３,５-치환된 피페리딘 화합물
EP1985297A1 (en) * 2006-01-27 2008-10-29 Japan Tobacco, Inc. Carboxylic acid compound and use thereof
TWI385161B (zh) 2006-02-02 2013-02-11 Mitsubishi Tanabe Pharma Corp 含氮雜雙環化合物
SI1984357T1 (sl) 2006-02-17 2014-02-28 Rigel Pharmaceuticals, Inc. Spojine 2,4-pirimidindiamina za zdravljenje ali preventivo avtoimunih bolezni
PT2794600T (pt) 2011-12-22 2018-03-13 Novartis Ag Derivados de 2,3-di-hidro-benzo[1,4]oxazina e compostos relacionados como inibidores de fosfoinositídeo-3-cinase (pi3k) para o tratamento de, por exemplo, artrite reumatoide
CN115181264B (zh) * 2022-07-20 2023-05-23 中国航空工业集团公司济南特种结构研究所 一种苯并噁嗪中间体及其制备方法和聚苯并噁嗪树脂制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1595863C3 (de) * 1966-08-11 1978-03-02 Knoll Ag, 6700 Ludwigshafen 4-Piperidinoacetyl-3,4-dihydro-(2H)-l,4-benioxazin und Verfahren zu dessen Herstellung
GB1173942A (en) * 1967-06-06 1969-12-10 Bellon Labor Sa Roger New 2,3-Dihydro-1,4-Benzoxazines
EP0076075B1 (en) * 1981-09-25 1986-11-20 Beecham Group Plc Pharmaceutically active benzopyran compounds
JPS61215381A (ja) * 1985-03-22 1986-09-25 Ube Ind Ltd ベンゾオキサジン誘導体および除草剤
NZ222843A (en) * 1986-12-22 1989-10-27 Ortho Pharma Corp Benzoxazinyl- and benzothiazinyl-tetrahydropyridazinones and intermediates, and medicaments
JPS63270678A (ja) * 1987-04-30 1988-11-08 Mitsui Petrochem Ind Ltd 新規含窒素化合物
EP0290863A3 (en) * 1987-05-09 1989-03-15 Nihon Tokushu Noyaku Seizo K.K. Benzoxazine derivative, process and intermediates for its preparation and its use as herbicide
EP0298542B1 (en) * 1987-07-07 1990-12-12 Shell Internationale Researchmaatschappij B.V. Process for preparing thiophene derivatives
GB8800199D0 (en) * 1988-01-06 1988-02-10 Beecham Group Plc Pharmaceutical preparation

Also Published As

Publication number Publication date
AU641953B2 (en) 1993-10-07
TW224941B (US07825116-20101102-C00007.png) 1994-06-11
NO904839D0 (no) 1990-11-07
EP0432893A2 (en) 1991-06-19
KR950007757B1 (ko) 1995-07-14
AU6594790A (en) 1991-06-06
JPH0774208B2 (ja) 1995-08-09
JPH04178375A (ja) 1992-06-25
KR910009682A (ko) 1991-06-28
PT95798A (pt) 1991-09-13
EP0432893A3 (en) 1991-07-10
IE904013A1 (en) 1991-05-08
PH30439A (en) 1997-05-09
FI905510A0 (fi) 1990-11-07
HU211282A9 (en) 1995-11-28

Similar Documents

Publication Publication Date Title
NO904839L (no) Fremgangsmaate for fremstilling av benzoxazinderivater.
NO964871L (no) Nye agonistforbindelser
HU913283D0 (en) Process for the production of hydroximethyl-(methylene-cyclopentyl)-purines and pirimidines, their medically usable salts, and of medical preparations containing them
MY102016A (en) Thiazolidinedione derivatives, their production and use.
NO862426D0 (no) Fremgangsmaate for fremstilling av pyridobenzoksazinderivater.
NO176356C (no) Analogifremgangsmåte for fremstilling av nye terapeutisk aktive pyrazolopyridinforbindelser
NO166448C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolidindioner.
NO179674C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive, heterosykliske N-oksidderivater av substituerte benzo[5,6Åsyklo-heptapyridiner
NO890723D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 3-alkenyl-1-azabicyklo(3.2.0)hept2-en-2-karboksylsyrederivater.
NO173139C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-aminopyrimidinonderivater
NO880731L (no) Fremgangsmaate for fremstilling av farmasoeytisk aktive naftalenderivater.
ATE110727T1 (de) Phthalinidderivat, pharmazeutische zubereitung und verwendung.
NO882334D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive alkansulfonanilid-derivater.
NO881835L (no) Fremgangsmaate for fremstilling av terapeutisk aktive bicykliske forbindelser.
NO870998D0 (no) Fremgangsmaate for fremstilling av nye, terapeutisk aktive acetamid-derivater.
NO171722C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive, nye tetralinderivater
NO20013601L (no) Nye morfolinobenzamidsalter
ES2016305B3 (es) Compuestos de piperazina, procedimiento para prepararlos y composicion farmaceutica y su uso.
NO893784L (no) Fremgangsmaate for fremstilling av nye, terapeutisk aktiveimidazolderivater.
HUT46214A (en) Process for producing medical preparation suitable for treatment of peptic ulcer
NO164170C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-benzhydryl-4-cinnamyl-piperazinderivater.
NO890691D0 (no) Fremgangsmaate for fremstilling av nye basiske substituerte 5-halogen-tienoisotiazol-3(2h)-on-1,1-dioksider og farmasoeytiske preparater derav.
NO167982C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive penemderivater.
NO873571L (no) Fremgangsmaate for fremstilling av et terapeutisk virksomtpreparat.
HU912216D0 (en) Process for the production of purinyl-and pirimidinyl - tetrahydrofurane derivatives and medical preparations containing them